Impact of conditioning on outcome of hematopoietic stem cell transplantation for wiskott-aldrich syndrome

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 6, 2013, Pages

  Stepensky, Polina ^a   Krauss, Aviva ^b   Goldstein, Gal ^c   Zaidman, Irena ^d   Elhasid, Ronit ^d   Bielorai, Bela ^c   Somech, Raz ^c   Or, Reuven ^a   Stein, Jerry ^b   Revel Vilk, Shoshana ^a   Weintraub, Michael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c Sheba Hospital   (Israel)

^d MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

hematopoietic stem cell transplantation; matched donors; types of conditioning; Wiskott Aldrich syndrome

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALLOPURINOL; BUSULFAN; CD34 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; TREOSULFAN;

ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; CHILD; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG OVERDOSE; ENGRAFTMENT; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISRAEL; LIVING DONOR; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTOPENIA; TOTAL PARENTERAL NUTRITION; WHOLE BODY RADIATION; WISKOTT ALDRICH SYNDROME;

CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WISKOTT-ALDRICH SYNDROME;

EID: 84881477608     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318279cbfc     Document Type: Article

References (22)

1. Wiskott A. Familial congenital Werlhof's disease? [German]. Monatsschr Kinderheilkd. 1937;68:212-216.
2. Ochs HD, Filipovich AH, Veys P, et al. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15(suppl): 84-90.
3. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78: 635-644.
4. Ochs HD, Rosen FS. The Wiskott-Aldrich syndrome. In: Ochs HD, Smith ECI, Puck JM, eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. New York: Oxford University Press; 2006:454-469.
5. Pai SY, Notarangelo LD. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. Immunol Allergy Clin North Am. 2010;30:179-194.
6. Bach FH, Albertini RJ, Joo P, et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364-1366.
7. Boztug K, Schmidt M, Schwarzer A, et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med. 2010;363:1918-1927.
8. Parkman R, Rappeport J, Geha R, et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978;298:921-927.
9. Ozsahin H, Le Deist F, Benkerrou M, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr. 1996;129:238-244.
10. Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011;118:1675-1684.
11. Diaz de Heredia C, Ortega JJ, Diaz MA, et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant. 2008;41:627-633.
12. Knutsen AP, Steffen M, Wassmer K, et al. Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J Pediatr. 2003;142:519-523.
13. Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Longterm outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008;111:439-445.
14. Stein J, Davidovitz M, Yaniv I, et al. Accidental busulfan overdose: enhanced drug clearance with hemodialysis in a child with Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2001;27:551-553.
15. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft versus host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
16. Pai SY, DeMartiis D, Forino C, et al. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant. 2006;38:671-679.
17. Munoz A, Olive T, Martinez A, et al. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatr Hematol Oncol. 2007;24:393-402.
18. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.
19. Friedrich W, Schultz C, Schulz A. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and-mismatched donors. Immunol Res. 2009;44:18-24.
20. Kobayashi R, Ariga T, Nonoyama S, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol. 2006;135:362-366.
21. Shin CR, Kim MO, Li D, et al. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant. 2012;47:1428-1435.
22. Slavin S, Aker M, Shapira MY, et al. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Clin Transpl. 2003;275-282.